Simulation of Chemoperfusion Treatment for Abdominal Carcinomatosis
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605534969 | ||
| 003 | CHVBK | ||
| 005 | 20210128100845.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20150501xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10517-015-2895-8 |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10517-015-2895-8 | ||
| 245 | 0 | 0 | |a Simulation of Chemoperfusion Treatment for Abdominal Carcinomatosis |h [Elektronische Daten] |c [V. Bespalov, O. Belyaeva, G. Kireeva, K. Senchik, A. Stukov, A. Belyaev] |
| 520 | 3 | |a Experimental perfusion system and technology for normothermic and hyperthermic intraperitoneal chemoperfusion are developed for the treatment of abdominal carcinomatosis in rats with transplanted ovarian cancer. MTD of cisplatin in normothermic intraperitoneal chemoperfusion and hyperthermic perfusion are 40 and 20 mg/kg, i.e. by 10- and 5-fold higher than the dose of this cytostatic for routine intraperitoneal injection. Normothermic intraperitoneal chemoperfusion with cisplatin increases median survival time by 200% (p=0.039) in comparison with intraperitoneal injection. | |
| 540 | |a Springer Science+Business Media New York, 2015 | ||
| 690 | 7 | |a intraperitoneal chemoperfusion |2 nationallicence | |
| 690 | 7 | |a ovarian cancer |2 nationallicence | |
| 690 | 7 | |a cisplatin |2 nationallicence | |
| 700 | 1 | |a Bespalov |D V. |u Laboratory of Cancer Chemotherapeutic Prevention and Oncopharmacology, N. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia |4 aut | |
| 700 | 1 | |a Belyaeva |D O. |u Laboratory of Cancer Chemotherapeutic Prevention and Oncopharmacology, N. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia |4 aut | |
| 700 | 1 | |a Kireeva |D G. |u Laboratory of Cancer Chemotherapeutic Prevention and Oncopharmacology, N. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia |4 aut | |
| 700 | 1 | |a Senchik |D K. |u Laboratory of Cancer Chemotherapeutic Prevention and Oncopharmacology, N. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia |4 aut | |
| 700 | 1 | |a Stukov |D A. |u Laboratory of Cancer Chemotherapeutic Prevention and Oncopharmacology, N. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia |4 aut | |
| 700 | 1 | |a Belyaev |D A. |u Laboratory of Cancer Chemotherapeutic Prevention and Oncopharmacology, N. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia |4 aut | |
| 773 | 0 | |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 159/1(2015-05-01), 81-84 |x 0007-4888 |q 159:1<81 |1 2015 |2 159 |o 10517 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10517-015-2895-8 |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10517-015-2895-8 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Bespalov |D V. |u Laboratory of Cancer Chemotherapeutic Prevention and Oncopharmacology, N. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Belyaeva |D O. |u Laboratory of Cancer Chemotherapeutic Prevention and Oncopharmacology, N. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Kireeva |D G. |u Laboratory of Cancer Chemotherapeutic Prevention and Oncopharmacology, N. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Senchik |D K. |u Laboratory of Cancer Chemotherapeutic Prevention and Oncopharmacology, N. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Stukov |D A. |u Laboratory of Cancer Chemotherapeutic Prevention and Oncopharmacology, N. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Belyaev |D A. |u Laboratory of Cancer Chemotherapeutic Prevention and Oncopharmacology, N. N. Petrov Research Institute of Oncology, Ministry of Health of the Russian Federation, St. Petersburg, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 159/1(2015-05-01), 81-84 |x 0007-4888 |q 159:1<81 |1 2015 |2 159 |o 10517 | ||